U.S. Direct-to-Consumer Genetic Testing Market - By Test (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomics Testing, Skincare Testing), By Technology (Targeted Analysis), By Distribution Channel & Forecast, 2023-2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationU.S. Direct-to-Consumer Genetic Testing Market - By Test (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomics Testing, Skincare Testing), By Technology (Targeted Analysis), By Distribution Channel & Forecast, 2023-2032
U.S. Direct-to-Consumer Genetic Testing Market Size
U.S. Direct-to-Consumer Genetic Testing Market size was valued at over USD 1.5 billion in 2022 and is poised to grow at over 11% CAGR from 2023 to 2032, driven by the growing occurrence of genetic disorders across the globe.
Growing incidence of genetic diseases such as breast cancer, colon cancer, and achondroplasia is likely to increase the demand for DTC tests. As per US CDC, nearly 264,000 cases of breast cancer are diagnosed in women, and around 2,400 in men, annually in the US. Another estimate from the American Cancer Society Data suggests that the country reported 106,180 new cases of colon cancer in 2022. This has elevated the demand for high-quality DTC genetic tests, that are capable of diagnosing genetic disorders much earlier, which has effectively decreased mortality rates among cancer patients, augmenting industry expansion.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| U.S. Direct-to-Consumer Genetic Testing Market Size in 2022 | USD 1.5 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 11% |
| 2032 Value Projection | USD 4.5 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 60 |
| Tables, Charts & Figures | 66 |
| Segments covered | Test Type, Technology and Distribution Channel |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Defects in DTC testing may constrain industry development
Hey there! So, it turns out that those over-the-counter genetic tests you can buy online might not be as reliable as we thought. A study by a big name in genetic testing, Ambry Genetics, found that these tests can give you a whopping 40% false positives! That's four out of every ten people getting a "positive" result when they don't actually have the disease. Understandably, this is making doctors nervous about using these tests in their practices. They don't want to put their patients at risk. So, as doctors become more cautious, the demand for these home tests is starting to drop. Another thing stalling their popularity is privacy concerns. The genetic data these tests give you can be easily shared publicly. You know, companies out there could use it for their own purposes without your permission. And that's not something people are thrilled about.
U.S. Direct-to-Consumer Genetic Testing Market Analysis
With respect to test, the U.S. DTC genetic testing market share from predictive testing segment is poised to grow at a 13% CAGR through 2023 to 2032. The increasing incidence rate of chronic and genetic diseases in the region is likely to drive the segment progression. The disease load of inherited ailments such as cystic fibrosis, sickle cell anemia, thalassemia, and hemophilia in growing at a rapid pace in the U.S., creating a higher growth impetus for the DTC test sector.
In the race for better health, the US market for genetic tests sold straight to consumers is on fire! A key part of this boom is the use of "SNP chips," which analyze your DNA at a crazy-detailed level. Picture these chips as microscopic detectives, studying your genes like blueprints. They can spot tiny changes, like a single letter out of place. And these tiny tweaks are like warning signs, hinting at potential health issues down the road. One amazing example is how SNP chips have helped identify 1300 mutations linked to the BRCA2 gene, which can trigger hereditary cancers. So, you get a sneak peek into your genetic future, empowering you to make informed choices for a healthier life.
Based on distribution channel, the U.S. DTC genetic testing market size from online platforms was valued at over USD 1.2 billion in 2022, driven by increasing consumer preference for online shopping and the popularity of tests such as 23andme and ancestry. Meanwhile, rising healthcare investments in the region is also fostering the market outlook.
With increasing per capita income and rising consumer awareness, leading players in the field are focusing on consolidating a presence on e-commerce and online retail platforms to make their products more easily accessible to customers.
U.S. Direct-to-Consumer Genetic Testing Market Share
Some leading U.S. DTC genetic testing market players include
- Ancestry
- Easy DNA
- 23andMe, Inc.
- HomeDNA
- Counsyl
- Living DNA Ltd.
- Pathway genomics
Many of these companies are focusing on product innovations to keep ahead of the competition. For example, in January 2022, 23andMe, a consumer genetics and research firm, received FDA approval for its DTC genetic test on a hereditary prostate cancer marker. This strategic move will help the company enhance its position in the market landscape.
Impact of COVID-19 on the U.S. direct-to-consumer genetic testing market trends
The COVID-19 pandemic impacted the U.S. DTC genetic testing industry positively as the prohibition of clinical genetic testing led to the adoption of telemedicine-based counselling and consultations. The lockdowns, which led to the temporary closure of clinical practices, spurred the adoption of online medicines and digital health services as people attempted to take care of their health needs while staying in the safety of their homes.
The U.S. DTC genetic testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments
Click here to Buy Section of this Report
By Test
- Carrier testing
- Predictive testing
- Ancestry & Relationship Testing
- Nutrigenomics Testing
- Skincare Testing
- Others
By Technology
- Targeted analysis
- Single nucleotide polymorphism (SNP) chips
- Whole genome sequencing [WGS]
By Distribution Channel
- Online platforms
- Over-the-Counter
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy